Priyank Garg

Correspondance: Assistant Professor, Dept. of Ophthalmology, LLRM Medical College, Meerut, UP

3 articles

  1. Articles 5 Apr 2020 26 min read

    Diabetic Maculopathy

    Diabetic maculopathy is the most common cause of visual impairment in patients with diabetes mellitus. Classification Diabetic maculopathy is classified as – Exudative Maculopathy Ischemic Maculopathy Mixed Maculopathy 1. Exudative Maculopathy (Diabetic Macular Edema) It is diagnosed stereoscopically as retinal thickening within 1 disc diameter of the center of the macula using fundus biomicroscopy. To characterize the severity of macular edema and for treatment guidelines, the term clinically significant macular edema (CSME) is used. Macular edema is clinically significant if one of the following conditions is present: Retinal thickening at or within 500 mm of the center of the macula; and/or Hard exudates at or within 500 mm of the center of the macula if associated with thickening of the adjacent retina; and/or A zone or zones of retinal thickening 1 disk area in size, at least part of which is within 1 disk diameter of the macular center. It is more common in type 2 diabetes (Adult

  2. Articles 5 Apr 2020 10 min read

    Pseudophakic Cystoid Macular Edema

    Pseudophakic cystoid macular edema (PCME) is a common cause of visual impairment after cataract surgery. This article systematically reviews and discusses the epidemiology, risk factors, diagnosis, and treatment of PCME, with a focus on advances in the past 1–2 years.In 1953, Irvine described a cystoid macular edema (CME) that specifically arised after cataract surgery.1 Gass and Norton subsequently studied the characteristics of the new disease entity with fluorescein angiography.2,3 Despite advances in cataract surgery, cystoid macular oedema (CMO) is still recognised as one of the most common causes of poor visual outcome following cataract surgery.4 Clinical cystoid macular edema(CCME) produces a variable degree of eyesight deterioration, in a percentage between 0.2 and 13%of patients operated for cataract with or without complications.5,6,7 Studies have shown that 12% of patients may have retinal thickening following uncomplicated cataract surgery.8 Retinal thickening most commonl

  3. Articles 5 Apr 2020 20 min read

    Central Serous Choroidopathy

    Introduction Central serous chorioretinopathy (CSC) is one of several chorioretinal disorders characterized by serous detachment of the neurosensory retina and ? or the retinal pigment epithelium (RPE). CSC is one of the 10 most common diseases of the posterior segment of the eye and a frequent cause of mild to moderate visual impairment.1 History of the disease2,3,4,5,6 1866 – Von graefe – first described the disease as recurrent serous retinitis. 1916 – Fuch’s work on the disease was appreciated. 1927 – Horniker – named disease as “Central Angiospastic Retinitis” 1930 – Walsh & Sloane – “idiopathic flat detachment of macula” 1930 – Gifford and Marquardt - Theory on Angioneurotic diathesis. 1953 – Klien – theory on autonomic nervous system dysfunction. 1950’s – Bennett & Maumenee – spectrum of macular disciform degeneration. 1955 – Bennett – “central serous retinopathy” 1960’s – Maumenee and Gass – FA appearance of CSC. 1967 – Gass – “central serous choroidopathy” Definition Active CS